ROSEMARY RIVAS: Open Payments
NPI 1821044751 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 5 payments from 5 companies in 2025. Trend: 2023 $660 · 2024 $429 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $133 |
| Lilly USA, LLC | 1 | $125 |
| Novo Nordisk Inc | 1 | $122 |
| Janssen Biotech, Inc. | 1 | $45 |
| Exact Sciences Corporation | 1 | $16 |
Products named: AUSTEDO XR, KISUNLA, Wegovy, DARZALEX, The Cologuard Plus Collection Kit.
Industry payments across TX — which companies pay providers there.
